FIRST SCIENTIFIC INC
SC 13D/A, 2001-01-12
CHEMICALS & ALLIED PRODUCTS
Previous: QUIKBIZ INTERNET GROUP INC, 4, 2001-01-12
Next: FIRST SCIENTIFIC INC, 8-K, 2001-01-12




                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                 SCHEDULE 13D/A


                    Under the Securities Exchange Act of 1934
                               (Amendment No. 2)*

                             First Scientific, Inc.
                                (Name of Issuer)

                          Common Stock, $.001 par value
                         (Title of Class of Securities)

                                   33620G 10 5
                                 (CUSIP Number)

                              James G. Swensen, Jr.
                        136 South Main Street, Suite 318
                           Salt Lake City, Utah 84101
                                  801-961-8800
                 (Name, Address, and Telephone Number of Person
                Authorized to Receive Notices and Communications)

                                December 31, 2000
             (Date of Event Which Requires Filing of this Statement)

If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  which is the subject of this  Schedule 13D, and is filing this
schedule because of Rule 13d-1(e),  13d-1(f) or 13-1(g), check the following box
[ ].

* The remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent   amendment   containing   information  which  would  alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).



<PAGE>



CUSIP No. 33620G 10 5

1.       NAME OF REPORTING PERSON
         S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS

         Aspen Capital Resources, LLC

2.       CHECK THE APPROPRIATE ROW IF A MEMBER OF A GROUP (SEE
         INSTRUCTIONS)
         (a) [ ]
         (b) [ ]

3.       SEC USE ONLY




4.       SOURCE OF FUNDS (SEE INSTRUCTIONS)

         WC

5.       CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
         ITEM 2(D) OR 2(E)                                                   [ ]

6.       CITIZENSHIP OR PLACE OF ORGANIZATION

         Utah

7.       SOLE VOTING POWER

         16,624,486  Shares  consisting  of 4,800  Shares  of  Common  Stock and
         16,619,686  Shares as to which the  Reporting  Person has voting rights
         pursuant to the Series 2000-A Convertible Preferred Stock

8.       SHARED VOTING POWER

         0 Shares

9.       SOLE DISPOSITIVE POWER

         16,624,486  Shares  consisting  of 4,800  Shares  of  Common  Stock and
         16,619,686  Shares as to which the  Reporting  Person has voting rights
         pursuant to the Series 2000-A Convertible Preferred Stock

ASPEN: First Scientific, Inc.                                       Dec 31, 2000
                                       -1-

<PAGE>



10.      SHARED DISPOSITIVE POWER

         0 Shares

11.      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

         16,624,486  Shares  consisting  of 4,800  Shares  of  Common  Stock and
         16,619,686  Shares as to which the  Reporting  Person has voting rights
         pursuant to the Series 2000-A Convertible Preferred Stock

12.      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
         SHARES (SEE INSTRUCTIONS)

13.      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

         41.9%

14.      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

         OO



ASPEN: First Scientific, Inc.                                       Dec 31, 2000
                                       -2-

<PAGE>



         This Amendment No. 2 to the Statement on Schedule 13D relates to shares
of Common Stock, par value $0.001 per share (the "Shares"), of First Scientific,
Inc.,  a Delaware  corporation  (the  "Company")  held for the  account of Aspen
Capital Resources, LLC (the "Reporting Person"). Capitalized terms not otherwise
defined  herein have the meanings  given in the  Statement on Schedule 13D filed
with respect to the reporting  date of August 14, 2000.  This Amendment is filed
pursuant to Rule 13d-2 of the Securities Exchange Act of 1934, as amended.

         Item 5 of Schedule 13D are hereby amended and restated in its entirety,
as follows:

Item 5.   Interest in Securities of the Issuer

         (a) - (b) As of December 31, 2000, the Reporting  Person was the holder
of 4,800  Shares and 3,652  shares of the Series  2000-A  Convertible  Preferred
Stock of the Company.  The  Preferred  Stock is not  convertible  until April 3,
2001,  however,  the Reporting Person has the power to vote the number of Shares
into which the Preferred Stock is convertible as though immediately convertible.
The  Conversion  Price for the  Preferred  Stock is 80% of the  average of the 3
lowest  closing  bid prices  during the 15 trading  days  preceding  the date of
conversion.

         Because the Preferred Stock is convertible into Shares at the option of
the Reporting  Person pursuant to the foregoing  formulas,  the actual number of
Shares  which  would be owned  by the  Reporting  Person  upon  conversion  will
fluctuate.  However,  for purposes of this filing, the Preferred Stock is deemed
converted as of the reporting date.

         On the basis of the  foregoing,  the Reporting  Person may be deemed to
beneficially own, directly or indirectly,  16,624,486, or 41.9% of the Company's
outstanding  Shares as of the reporting date.  Such  calculation is based on the
Company's  outstanding  Shares,  after  giving  effect to Shares  issuable  upon
conversion of the Preferred Stock owned by the Reporting Persons.

         The Reporting  Person may be deemed to have the power to vote or direct
the  vote,  and  to  dispose  or  to  direct  the  disposition  of,  the  Shares
beneficially  owned by it.  In  addition,  Joe K.  Johnson,  is  manager  of the
Reporting Person. As such, he has been granted voting power and investment power
over  investments  of the  Reporting  Person,  including  the  Shares,  and  may
therefore  be deemed to control,  directly or  indirectly,  the Shares  reported
hereby.

         (c) Schedule I lists transactions in the Shares by the Reporting Person
since the most recent  filing of an amendment  to Schedule  13D,  including  the
name,  date,  amount of  securities  involved,  and  price  per unit.  Except as
otherwise  indicated,  all acquisitions of Shares and all dispositions of Shares
were executed through market  transactions.  There were no other transactions in
the Shares by the Reporting Person since the most recent filing of Schedule 13D.

         (d) No  person  is known by the  Reporting  Person to have the right to
receive or the power to direct the receipt of  dividends  from,  or the proceeds
from the sale of, any Shares beneficially owned by the Reporting Person.

ASPEN: First Scientific, Inc.                                       Dec 31, 2000
                                       -3-

<PAGE>



         (e)  Not applicable.

SIGNATURE

         After reasonable  inquiry and to the best of my knowledge and belief, I
certify that the information  set forth in this statement is true,  complete and
correct.

Dated:  December 31, 2000

ASPEN CAPITAL RESOURCES, LLC


By:      /s/
     -------------------------------------------------------------
         Joe K. Johnson, Manager




ASPEN: First Scientific, Inc.                                       Dec 31, 2000
                                       -4-

<PAGE>


                                   SCHEDULE I


Title of Security Transaction           Securities Acquired (A) and Disposed (D)
                    Date                ----------------------------------------
                                          Number of                    Price
                                          Shares                       Per Share

Common Stock      12/08/00                    15,000 D                   $ .33
Common Stock      12/11/00                    65,000 D                   $ .31
Common Stock      12/12/00                    10,000 D                   $ .29
Common Stock      12/13/00                   125,000 D                   $ .25
Common Stock      12/14/00                    10,000 D                   $ .24
Common Stock      12/15/00                    55,000 D                   $ .52
Common Stock      12/18/00                    30,000 D                   $ .57
Common Stock      12/19/00                    10,000 D                   $ .53
Common Stock      12/27/00                   425,000 D                   $ .35
Common Stock      12/29/00                     5,000 D                   $ .27



ASPEN: First Scientific, Inc.                                       Dec 31, 2000
                                       -5-



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission